Search Results - Jae Ho Byun

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: A Systematic Review and Meta-Analysis by Dong Wook Kim, Sang Hyun Choi, Ji Sung Lee, So Yeon Kim, So Jung Lee, Jae Ho Byun

    Published in Diagnostics (2021-02-01)
    Get full text
    Article


  2. 2

    Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer by Hye Sung Won, Yong-Seok Kim, Kyung Jin Seo, Sun-Young Jun, Der Sheng Sun, Mihong Choi, Jung-Sook Yoon, Jae Ho Byun

    Published in Frontiers in Oncology (2025-08-01)
    Get full text
    Article


  3. 3

    Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis by Dong Hwan Kim, Sang Hyun Choi, Ju Hyun Shim, So Yeon Kim, Seung Soo Lee, Jae Ho Byun, Kyung Won Kim, Joon-Il Choi

    Published in Diagnostics (2021-09-01)
    Get full text
    Article


  4. 4

    Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors by Subin Heo, Hyo Jung Park, Hyoung Jung Kim, Jung Hoon Kim, Seo Young Park, Kyung Won Kim, So Yeon Kim, Sang Hyun Choi, Jae Ho Byun, Song Cheol Kim, Hee Sang Hwang, Seung Mo Hong

    Published in Cancer Imaging (2024-02-01)
    Get full text
    Article


  5. 5

    613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06... by Jae Ho Byun, Jeeyun Lee, Kyong Hwa Park, Eun Joo Kang, In Gyu Hwang, Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, Jason K Sa, Sook Ryun Park, Yu Kim, Woo Kyun Bae, Jung Sun Kim, Sang Shin

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06) by Jae Ho Byun, Jeeyun Lee, Kyong Hwa Park, Eun Joo Kang, Sang Joon Shin, In Gyu Hwang, Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, Jason K Sa, Sook Ryun Park, Jung Sun Kim, Yu Jung Kim, Woo Kyun Bae, Won Jin Chang, Eun-Ok Kim

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Get full text
    Article


  7. 7

    Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cyste... by Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, Jung Hoon Kim, Hee Jun Kim, Chi Hoon Maeng, Inkeun Park, Byeong Seok Sohn, Jung A. Kim, Kyung Hee Lee, Do Hyoung Lim, Hyun Chang, Sung Min Kim, Ho Young Kim, Hunho Song, Seungtaek Lim, Jae Ho Byun, Hyun Ae Jung

    Published in Cancer Medicine (2019-09-01)
    Get full text
    Article


  8. 8

    Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)Research... by Hee Kyung Ahn, Jee Hung Kim, Su-Jin Koh, Joohyuk Sohn, Myoung Joo Kang, Kyung Hae Jung, Kyoung Eun Lee, Jieun Lee, Sung Ae Koh, Yee Soo Chae, Jae Ho Byun, In Hae Park, Hee-Jun Kim, Jee Hyun Kim, Han Jo Kim, Joo Young Jung, Jung Lim Lee, Yoon Young Cho, Kyong Hwa Park, Ji-Yeon Kim, Seock-Ah Im, Yeon Hee Park

    Get full text
    Article


  9. 9

    Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15) by Jieun Lee, Dae-Won Lee, Min Hwan Kim, Jee Hung Kim, Ju Won Kim, Jae-Ho Byun, Kyoung Eun Lee, Myoung Joo Kang, Su-Jin Koh, Soojung Hong, Hye Sung Won, Han Jo Kim, In Hae Park, Seong Hoon Shin, Sun Kyung Baek, Seul-Gi Kim, Sung Ae Koh, Joo Young Jung, Ji-Yeon Kim, Gun Min Kim, Kabsoo Shin, In Sook Woo, Hyun Seon Kim, Seock-Ah Im, Yeon Hee Park

    Published in Breast (2025-08-01)
    Get full text
    Article


  10. 10

    A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) by Sun Kyung Baek, Jae-ho Jeong, KyungHae Jung, Hee Kyung Ahn, Min Hwan Kim, Joohyuk Sohn, In Hae Park, Jin Seok Ahn, Dae-Won Lee, Seock-Ah Im, Sung Hoon Sim, Keun Seok Lee, Jee Hyun Kim, Hyun-Jeong Shim, Yeesoo Chae, Su-Jin Koh, Hyorak Lee, Jieun Lee, Jae-Ho Byun, Youngmi Seol, Eun Mi Lee, Hee-Jung Jee, Hyonggin An, Eun Byeol Park, Young Ju Suh, Kyoung Eun Lee, Yeon Hee Park

    Published in Therapeutic Advances in Medical Oncology (2024-01-01)
    Get full text
    Article


  11. 11

    Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers by Ji Yoon Lee, Ji Won Lee, Min Sung Chung, Jong Gwon Choi, Sung Hoon Sim, Hyo Jeong Kim, Jeong Eun Kim, Kyoung Eun Lee, Yeon Hee Park, Myoung Joo Kang, Mi Sun Ahn, Yee Soo Chae, Ji Hyun Park, Jee Hyun Kim, Gun Min Kim, Jae Ho Byun, Keon Uk Park, Ju Won Kim, Seung Pil Jung, Jung Hyun Lee, Jung Seok An, Byunghyun Jang, Dayoung Yoon, Jiwon Kim, Jisoo Hong, Harim Koo, Kyu Ran Cho, Cheol Yong Kim, Jason K. Sa, Kyong Hwa Park

    Published in BMC Medicine (2024-09-01)
    Get full text
    Article


Search Tools: